Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- COL (ret) George E Peoples, MD, FACS
LumaBridge
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sarcoma Oncology Research Center, Llc
Santa Monica, California, United States
- St Joseph Heritage Healthcare
Santa Rosa, California, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- University of Miami
Deerfield Beach, Florida, United States
- Memorial Breast Cancer Center
Hollywood, Florida, United States
- University of Miami
Kendall, Florida, United States
- University of Miami
Miami, Florida, United States
- Florida Cancer Research Institute
Plantation, Florida, United States
- University of Miami
Plantation, Florida, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Medstar (good Samaritan Hospital)
Baltimore, Maryland, United States
- Medstar Health (union Memorial Hospital)
Baltimore, Maryland, United States
- the Valley Hospital
Paramus, New Jersey, United States
- New Mexico Cancer Care Alliance/presbyterian Cancer Center
Albuquerque, New Mexico, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Tisch Cancer Institute/icahn School of Medicine at Mount Sinai
New York, New York, United States
- North Shore Hematology Oncology Associates
The Bronx, New York, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Texas Oncology (cancer Care Centers of South Texas)
San Antonio, Texas, United States
- University of Virginia Human Immune Therapy Center
Charlottesville, Virginia, United States
- Providence Regional Medical Center
Everett, Washington, United States
- Ascension/ Columbia St. Mary'S
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 31 Dec 2021
- Completion
- 31 Dec 2021
- Last update posted
- 12 Dec 2023
- Registered enrollment
- 100
- Registry id
- NCT02297698
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.